Influenza and its complications

Česká verzia

Authors: Adam Vitouš; František Stejskal
Authors place of work: Technická univerzita Liberec, Klinika infekčních nemocí, 2. LF UK a Nemocnice Na Bulovce, Praha ; Ústav imunologie a mikrobiologie, 1. LF UK a VFN, Praha ; Infekční oddělení, Krajská nemocnice Liberec, a. s.
Published in the journal: Vnitř Lék 2020; 66(6): 360-362
Category:

Summary

Influenza is viral acute respiratory illness. During winter season flu occurs in local epidemics of various magnitude. Influenza causes substantial loss of workdays, human suffering, and significant mortality rate in population, despite the existing treat‑ ment and effective vaccination.

Keywords:

vaccine – flu – influenza – infection – complications

Zdroje

1. Drake JW. Rates of spontaneous mutation among RNA viruses. Proc Natl Acad Sci, USA 1993. 90(9): 4171–4175.

2. Kilbourne ED. Influenza pandemics of 20th century. Emerg Infect, DiS. 2006 Jan. 12(1): 9–14.

3. Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (NCIRD), www.cdc.gov/flu/about/disease/spread.htm

4. Bridges CB, Kuehnert MJ, Hall CB. Transmission of influenza: implications for control in health care settings. Clin Infect, DiS. 2003; 37: 1094–1101 10.1086/378292.

5. Avian influenza: fact sheet. World Health Organization. www.who.int/mediacentre/ factsheet/avian_influenza/en/print.html

6. Tasher D, Stein M, Simoea EA, et al. Invasive bacterial infections in relation to influenza outbreaks, 2006–2010. Clin Inf, DiS. 2011 Dec. 53(12): 1199–207.

7. Won Suk Choi, Ji Hyeon Baek, Yu Bin Seo, et al. Severe influenza treatment guidelines. Transgovernmental Enterprise for Pandemic Influenza in Korea Korean J Intern Med 2014; 29: 132–147. 2014 pISSN 1226‑3303 eISSN 2005–6648 http://www.kjim.org.

8. Kotey E, Lukosaityte D, et al. Current and Novel Approaches in Influenza Management. Vaccines (Basel). 2019 Jun; 7(2): 53.9.

9. Kwong JC, Schwartz KL, Cempitelli MA, et al. Acute Myocardial Infarction after Laboratory ‑confirmed Influenza Infection. N Engl J Med 2018, 378: 345. 10.

10. Waren ‑Gash C, Bhaskaran K, Hayward A, et al. Circulating influenza virus, clima‑ tic factors and acute myocardial infarction: a time series study in England and Wales and Hong Kong. J Infect Dis 2011. 203: 1710.

11. Naghavi M, Barlas Z, Siadaty S, et al. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 2000;102:3039–45.

12.Puig ‑Barbera J, Diez ‑Domingo J, Varea A, et al. Effectiveness of MF59‑adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly. Vaccine 2007; 25: 7313–7321.

13. Siriwardena AN, Gwini SM, Coupland CA. Influenza vaccination, pneumococcal vaccination and risk of acute myocardial infarction: matched case ‑control study. CMAJ 2010; 182: 1617–1623.

14. Warren ‑Gash C, Blackburn R, et al. Laboratory ‑confirmed respiratory infections as triggers for acute myocardial infarction and stroke: a self ‑controlled case series analysis of national linked datasets from Scotland. European Respiratory Journal 2018 51: 1701794.